VEGFA and age-related macular degeneration: One such example is ADVM-022 (Adverum Biotechnologies), a gene therapy product for the treatment of neovascular age-related macular degeneration (AMD), consisting of rAAV2 encoding aflibercept (an anti-VEGF protein).